Human papillomavirus (HPV) have been recognized as oncogenic factor in cervical carcinoma. There was an increased incidence of cervical cancer in Chinese women. However, little is known about the prevalence of HPV genotypes in Chinese women with cervical cancer and risk factors of cervical cancer. Cervical exfoliated cells were prospectively collected from 792 women with cervical cancer referred for colposcopic examination. The individual HPV genotypes in these specimens were identified (HPV GenoArray test kit; Hybribio Ltd., Hong Kong). Meanwhile, the clinical data and laboratory result of these patients were gathered. HPV-positive was found in 588/792 (74.2%). The prevalence of the HR-HPV were 516/792 (65.2%). and 51.0% of these patients were infected with mixtures of HR genotypes. HPV positive rate in various clinical stages and differentiation degree of uterine cervical cancer had no statistical differences (P>0.05). HPV positive rate in squamous cancer and adeno-carcinoma had statistical differences respectively with other pathological types (P<0.05).The logistic regression analysis showed that HPV16 infection or HPV58 infection or age over 40 might increase the risk of carcinogennesis of the cervix. The infection rate and superinfection rate of HPV from Chinese women with disease of uterine cervix were high. The patients with HPV16 or HPV58 infection or age over 40 years were associated with increased risk of cervical cancer.
INTRODUCTION
The human papillomavirus (HPV) has been recognized as an oncogenic factor in cervical carcinoma and several other anogenital cancers in females and males (Bosch et al., 2002; Muñoz et al., 2006) . Moreover, approximately 26% of head and neck cancers are relevant to HPV infection (Gillison et al., 2004) . HPV is, more correctly, used to describe a heterogeneous group of small DNA viruses. Currently, more than 200 HPV genotypes have been identified, and the interest in studying HPV is focused on HPV associated with cervical cancer (Jung et al., 2004) . According to the Association of International *Corresponding author. E-mail: wym0577@163.com. Tel: +86-0577-8806-9592.
Cancer, HPV is classified as low-risk HPV (LR-HPV) or high-risk HPV (HR-HPV), depending on its oncogenic risk. Each year, 493000 new cases of cervical cancer are reported, and more than 80% of these cases occur in developing countries (Parkin et al., 2005; Mun˜oz et al., 2003) . There is an increased incidence of cervical cancer in Chinese women. Many results have shown variation in the infection rate of HPV. This variation occurred among different countries and even between different populations within countries and ranged from 22 to 100%. The reason for this variation was because of different races, different people, and so on Farjadian et al., 2003; Koshiol et al., 2008) . These studies only represented the HPV infection situation of the local or crowd, but provided the epidemiology data and the foundation for HPV. Epidemiological data showed that there were a few HPV types in China and, of the HPV types, the distribution in the different regions varied. It showed that the positivity rate of HPV DNA was 26.2% in the 99 cases of cervical cancer reported in Guangzhou in the last 3 decades. Five HPV genotypes were identified, including HPV16, 18, 33, 52 and 58 (Usubütün et al., 2009) . The data showed that the types that were prevalent with cervical intraepithelial neoplasia 1 (CIN 1) were HPV-52 (22.5%), HPV-16 (11.6%) and HPV-CP8304 (10.1%) and were located in the Fujian province, China (Wu et al., 2010) . The types, that were prevalent with cervical intraepithelial neoplasia 2 or 3 (CIN2/3) were HPV-16 (24.5%), HPV-33 (21.6%), and HPV-52 (19.6%). The types that were prevalent with carcinoma, including squamous cell carcinoma (SCC) and adenocarcinoma (ADCA), were HPV-16 (42.7%), HPV-18 (20.8%) and HPV-33 (12.5%) (Haverkos et al., 2005) .
We used the HybriBio GenoArray test for HPV genotyping. It showed that the HPV GenoArray test kit (GA) and the Roche Linear Array (LA) assays showed no significant difference in the rates of detection of genotypes detected by both HPV genotyping assays and oncogenic genotypes (Liu et al., 2010) . The GA and LA assays revealed either concordant or compatible genotyping results for 97.5% of the samples (Adab et al., 1997) . Recently, some scholars have compared the HCII and HPV GenoArray tests and showed that the results of both were highly consistent (Petry et al., 2003) . The results showed that there was a high level (93.8%) of agreement between the results of that assay and those of the Amplicor HPV test (Grisaru et al., 2008) . Thus, the HPV GenoArray test is an easy and reliable method for HPV genotyping. There is an increased incidence of cervical cancer in Chinese women.
However, little is known about the prevalence of the HPV genotypes in Chinese women with cervical cancer and the risk factors of cervical cancer. In this study, we assessed a large number of samples from cervical cancer patients by the HPV GenoArray test kit and analyzed the risk factors of carcinogennesis of the cervix by making use of a multi-factor method of progression logistic return analytic method to provide epidemiology data and the foundation of the HPV research.
MATERIALS AND METHODS

Patients and specimens
Cervical exfoliated cells were prospectively collected from 792 women with cervical cancer who were referred for colposcopic examination. These patients came from the Wenzhou Medical College affiliated with the first hospital and the second hospital of Wenzhou City and the third hospital of Wenzhou City, China, from January 2006 to May 2008. As the patients were entered into the study, the clinical data and laboratory results were gathered. This study was approved by the ethical board of the First Affiliated Hospital of Wenzhou Medical College, and all patients provided written informed consent to participate. The diagnosis of cervical cancer depended on histopathological results. In this study, 1360 chronic cervicitis and 660 cervical intraepithelial neoplasia cases Yumin et al. 1049 were studied. The clinical stage of cervical cancer was determined by FIGO 2009. The pathologic type and the degree of histological differentiation depended on the histopathological results. Dacron swabs were inserted into the endocervix by a clinician and rotated in both directions five times to collect the exfoliated cervical samples. These samples were stored at 4°C for up to 2 weeks before they were shipped at room temperature to the HPV research laboratory for HPV detection and genotyping. The patients' data were collected (including age, employment, clinical diagnosis, pathological diagnosis, clinical stage, histological types, ordinary data, menstruation history, marriage history, life style, family history, medical history, pregnancy history, educational background, etc.).
Genomic DNA isolation from cervical swab samples
Genomic DNA isolation was performed using the HPV DNA extraction kit according to the manufacturer's protocol (Hybribio Limited Corporation, Hong Kong). Briefly, 0.5 ml of the cervix of the uterus cell preservation fluid was centrifuged at 14000 rpm for 1 min. The supernatant was discarded, and the HPV DNA was extracted with the HPV DNA extraction reagent.
HPV genotyping
HPV genotyping was performed using the newly commercially introduced Hybribio HPV GenoArray Test kit (Hybribio Limited, Hong Kong).
RESULTS
The positive rate of HPV from patients with cervical cancer
Of the samples genotyped, 588/792 (74.2%) were HPV-positive. The prevalence of the HR-HPV was 516/792 (65.2%), and 51.0% of these patients were infected with mixtures of the HR genotypes. The spectrum of HPV infections in the patients with cervical cancer was principally HPV16. The infection rate of HPV and the infection rate of HR-HPV and the superinfection rate in patients with cervicitis and atypical hyperplasia of the cervix uteri and cervical cancer gradually increased (P<0.01). Cervical cancer was higher than other diseases of the cervix of the uterus ( 2 = 28.28, P<0.001), has the different cervix of the uterus disease HR-HPV infection rate obviously to be higher than the LR-HPV infection rate ( 2 =125.00, 102.17, 151.64, P <0.001), cervical cancer patient HPV overlap catches up with dyes rate is higher than other cervix of the uterus disease obviously ( The non-cervical cancer group included chronic cervicitis and cervical intraepithelial neoplasia positive rate in squamous cancer and adenocarcinoma showed significant differences compared with other pathological types ( 2 =3.855, P=0.032) ( Table 1 ). The data showed that the HPV infection of patients with cancer of the cervix was possibly related to squamous cancer and adenocarcinoma cancer.
According to related data (including general situation, menstrual history, number of pregnancies and deliveries, educational level, HPV infection, etc.), a logistic regression was performed to identify the risk factors for cervical cancer. The card side examination showed that associated risk factors of cervical cancer did not include educational level (X2), occupation (X3), menarche age (X4), menopause (X5), marriage (X9), second marriage (X10), alcohol consumption (X11) smoking (X12), or LR-HPV infection (X14) but did include age (X1) and HR-HPV infection (X13) ( Table 2) . A t-test showed that term birth (X6), abortion (X7) and procreation (X8) were also not associated risk factors of cervical cancer.
Taking the associated single factor and performing the non-conditional logistic regression analysis, we showed that age (X1) (Sig=0.015, Exp (B) = 2.12, 95% CI. for EXP (B) = 1.51~4.11) and HR-HPV infection (X13) (Sig=0.000, Exp B) = 2.51, 95% CI. for EXP (B) =1.00~4.36) were the main risk factors of cervical cancer. Multidimensional logistic regression was applied to analyze the age factor and the HR-HPV different hypotype infection and cervical cancer relationships. The result showed that HPV16 infections result in an increased (2.78 times) carcinogenesis risk of the cervix uterus (EXP (B) = 2.78, 95% CI =1.77~4.36, P<0.01). Similarly, 58 HPV infections showed a cervical cancer risk increase of 1.69 times (EXP 
DISCUSSION
In recent decades, developed countries have successfully reduced cervical cancer morbidity and mortality (FangHui et al., 2001) . It is very clear that HR-HPV is a cause of cervical cancer (Jian et al., 2006) , where it is found in approximately 83 percent of new cases in developing countries with HPV screening programs that are not well established or effective. In most of these countries, cervical cancer is the leading cause of cancer death among women (PingPing et al., 2006) . The close correlation between HPV infection and cervical cancer is well established, but there is a wide difference between the prevalence of infection and the occurrence of actual cancer. It is generally acknowledged that a minority of women who are infected with HPV will develop high grade intraepithelial lesions (HSILs) and still fewer will develop thoroughly evolved carcinoma. The co-infection of HPV, that is, including two or more than two types of HPV in the same patient, is one of the main unsolved problems associated with the current HPV diagnosis and HPV vaccination. The HybriBio GenoArray test for HPV genotyping makes use of both DNA amplification and HybriBio's proprietary flow-through hybridization technique to immediately identify 21 HPV subtypes, including five low-risk types (6, 11, 42, 43, 44) , 14 high-risk types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68) , and two intermediate-risk types (CP8304, 53). The test employs a macro-array format utilizing a nylon membrane to which the HPV genotype-specific oligonucleotides probes have been immobilized.
China is one of the developing countries in which the types of HPV infection that are associated with cervical cancer are different from those in other countries. The types of HPV infection associated with cervical cancer in other countries are mainly HPV16 and HPV18 (Mousavi-Jarrahi et al., 2006; Castellsagué et al., 2008) , while HPV16 and HPV 58 were predominant in China. The HPV detection rate of the total was 53.5%, HPV16 and HPV58 accounted for 31.9 and 7.6%, respectively. While the HPV18 infection rate was 1.0%, which was significantly lower than what was observed abroad (LiGeng et al., 2003) . It was showed that HPV meta-analysis of a global distribution of invasive cervical squamous cell carcinoma in 2007, more than 2/3 of the specimens detected HPV16 or 18, then followed by HPV45, 31,33,52,58 type. The study also analyzed the distribution of HPV in adenocarcinoma cervical cancer, the same in more than 2/3 of the samples detected HPV16 or 18, third place for the HPV45 type, the proportion of other subtypes are each less than 1.5%. According to a systematic review of data from the 2007 WHO/ICO HPV Information Centre and the published literature, it showed the detection rates of HPV16, HPV52, HPV18 were 2.1, 2.3, 0.8% and 1.0, 0.7, 0.7% from cytological normal women of Asia and East Asia. The Chinese Academy of Medical Sciences Cancer Institute scientists found that the HPV infection rate was 53.5%, of which HPV16 was 31.9% and HPV58 was 7.6%. The highest rate in China was in 1996, was found in the North of China and was mainly HPV16 and HPV58 and was the predominant HPV type in the South Yangtze River middle and lower regions. Other reports indicated that HR-HPV infection rate of patients with cervical cancer was 88. 4%~99.7%（Duttagupta C et al. 2002） , and these reports showed that HR-HPV in cervical cancer patients had a higher infection rate in China. Our study showed that the HPV infection rate of patients with cervical cancer was 74.2%, HR-HPV infection rate was 65.2% and the mixed infections rate was 51.0%. The infection rate and the mixed infection rate of cervical cancer were significantly higher than other cervical diseases. Our results were consistent with other studies, indicating HPV infections, especially HR-HPV infection, are closely related to cervical cancer. The spectrum of the HR-HPV type of cervical cancer is mainly HPV16 and HPV16 and may be the most important pathogenic HPV type in Chinese women with cervical cancer.
With regard to the relationship between HPV infection and the pathological types of cervical cancer, collected 85 studies, which included 10,058 cases of invasive cervical cancer. Of the total cases, 8550 were squamous cell carcinoma, adenocarcinoma and adenosquamous carcinoma, and 1508 of the cases showed that the HPV detection rate in squamous cell carcinoma was 87.3% by the HPV DNA test . These data showed that the HPV infection rate of all clinical stages of cervical cancer was not statistically significant (P>0.05) and that squamous cell carcinoma and adenocarcinoma was not significantly different. On the other hand, squamous cell carcinoma and adenocarcinoma were significantly different (P<0.05) when compared with other histological types of cervical cancer. In Chinese patients, HPV infection in squamous cell carcinoma and adenocarcinoma was unrelated to other pathological types. There were differences reported in the literature, which were due to other types of cervical adenocarcinoma, and the number of cases of cervical cancer in our study was lower.
Many studies found that extramarital sex, age of first sexual intercourse, production and frequency were risk factors of cervical cancer at home and abroad (Altekruse SF et al. 2003) . Further studies confirmed that HPV infection, especially HR-HPV infection, was a necessary factor for cervical cancer. Rong S (Rong et al., 2002) found that HR-HPV infection, number of sexual partners and family history of cancer were significantly associated with the incidence of cervical cancer. Similarly, It showed that HR-HPV infection is the main reason for CIN (Fang et al., 2007) . Our study used multiple logistic regression analysis and found that age and HR-HPV infections were risk factors of cervical cancer in Chinese women. Further analysis showed that HPV6 increased the risk of carcinogenesis of the cervix 2.78-fold. Similarly, 58 HPV infections increased the risk by 1.69-fold. Compared with women under the age of 40, women over 40 and infected with HPV, had a 1.63-fold increased risk of cervical cancer. These data suggested that HPV16 and HPV58 infection and age (>40 years old) may be the major risk factors of cervical cancer in Chinese women. The increased risk for the incidence of cervical cancer in women over the age of 40 may be because increased immunity is gradually disappearing or because of changes in hormone levels with age, which results in resurrection of the virus incubation period or the original infection of HPV causing persistent HPV infection.
The drawback of the HPV tests is that they detect only 23 common HPV types and thus, the epidemic strains found in some areas are not detected because they are not among the 23 common HPV types. Currently, many countries have developed and promoted of the HPV vaccine, which is helpful for the prevention of cervical cancer, but the effectiveness of the HPV vaccine against the HPV sub-types is minimal. l and would only be effective for girls with non-vaccine HPV infection and who were not sexually active. In contrast, it would not be effective for sexually active women with HPV infection. Thus, these are limits to further promotion of the HPV vaccine.
In summary, HPV cervical cancer in Chinese women had a higher prevalence of reproductive tract infection, and the HR-HPV infection rate was significantly higher than the LR-HPV infection rate. Therefore, HPV infection should arouse the attention of the society to strength the routine screening of HPV. The early detection of infection and timely intervention should be highly thought of.
